The IMPROVE study

Background and study design

Barry L. Carter, Daniel C Malone, Robert J. Valuck, Debra J. Barnette, Charles D. Sintek, Sarah J. Billups

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

An ongoing study of the impact of ambulatory care clinical pharmacists on patient outcomes at selected Veterans Affairs medical centers (VAMCs) is described. The IMPROVE (Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers) study will examine the effects of referring patients at high risk for drug-related problems to a pharmacist-managed monitoring program. Nine study sites from diverse geographic locations and small and large urban areas have been selected. Investigators visited each site to evaluate the structure of care, observe pharmacist-patient interactions and assess the level and documentation of pharmacists activities. A coordinating center will collect and process patient-specific data from the study sites to identify high-risk patients. It is expected that 500 intervention patients and 500 control patients from the nine VAMCs will complete all portions of the study. Intervention patients will be scheduled for medication assessments by ambulatory care pharmacists and will be monitored by pharmacists for at least 12 months. The coordinating center will track refill histories for intervention patients. Investigators will assess the activities performed by ambulatory care pharmacists to determine predictors of successful patient outcomes. The two groups will be compared with respect to change from baseline in quality of life and satisfaction with health care providers. A cost-benefit analysis will be undertaken to determine the impact of pharmaceutical care relative to total patient care costs. The main outcome results of the IMPROVE study are expected to be available in 1999. The IMPROVE project will be the first study of the impact of ambulatory care clinical pharmacists on patient outcomes.

Original languageEnglish (US)
Pages (from-to)62-67
Number of pages6
JournalAmerican Journal of Health-System Pharmacy
Volume55
Issue number1
StatePublished - 1998
Externally publishedYes

Fingerprint

Pharmacists
Ambulatory Care
Veterans
Pharmaceutical Services
Research Personnel
Geographic Locations
Managed Care Programs
Documentation
Health Personnel
Cost-Benefit Analysis
Patient Care
Quality of Life
Costs and Cost Analysis
Pharmaceutical Preparations

Keywords

  • Administration
  • Ambulatory care
  • Clinical pharmacists
  • Clinical pharmacy
  • Clinical studies
  • Costs
  • Department of Veterans Affairs
  • Economics
  • Errors, medication
  • Interventions Methodology
  • Outcomes
  • Patient care
  • Pharmaceutical care
  • Pharmaceutical services
  • Pharmacy, institutional, hospital
  • Prescriptions
  • Primary care
  • Toxicity

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Leadership and Management

Cite this

Carter, B. L., Malone, D. C., Valuck, R. J., Barnette, D. J., Sintek, C. D., & Billups, S. J. (1998). The IMPROVE study: Background and study design. American Journal of Health-System Pharmacy, 55(1), 62-67.

The IMPROVE study : Background and study design. / Carter, Barry L.; Malone, Daniel C; Valuck, Robert J.; Barnette, Debra J.; Sintek, Charles D.; Billups, Sarah J.

In: American Journal of Health-System Pharmacy, Vol. 55, No. 1, 1998, p. 62-67.

Research output: Contribution to journalArticle

Carter, BL, Malone, DC, Valuck, RJ, Barnette, DJ, Sintek, CD & Billups, SJ 1998, 'The IMPROVE study: Background and study design', American Journal of Health-System Pharmacy, vol. 55, no. 1, pp. 62-67.
Carter BL, Malone DC, Valuck RJ, Barnette DJ, Sintek CD, Billups SJ. The IMPROVE study: Background and study design. American Journal of Health-System Pharmacy. 1998;55(1):62-67.
Carter, Barry L. ; Malone, Daniel C ; Valuck, Robert J. ; Barnette, Debra J. ; Sintek, Charles D. ; Billups, Sarah J. / The IMPROVE study : Background and study design. In: American Journal of Health-System Pharmacy. 1998 ; Vol. 55, No. 1. pp. 62-67.
@article{da4461908fb9485796b3449d136b56b2,
title = "The IMPROVE study: Background and study design",
abstract = "An ongoing study of the impact of ambulatory care clinical pharmacists on patient outcomes at selected Veterans Affairs medical centers (VAMCs) is described. The IMPROVE (Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers) study will examine the effects of referring patients at high risk for drug-related problems to a pharmacist-managed monitoring program. Nine study sites from diverse geographic locations and small and large urban areas have been selected. Investigators visited each site to evaluate the structure of care, observe pharmacist-patient interactions and assess the level and documentation of pharmacists activities. A coordinating center will collect and process patient-specific data from the study sites to identify high-risk patients. It is expected that 500 intervention patients and 500 control patients from the nine VAMCs will complete all portions of the study. Intervention patients will be scheduled for medication assessments by ambulatory care pharmacists and will be monitored by pharmacists for at least 12 months. The coordinating center will track refill histories for intervention patients. Investigators will assess the activities performed by ambulatory care pharmacists to determine predictors of successful patient outcomes. The two groups will be compared with respect to change from baseline in quality of life and satisfaction with health care providers. A cost-benefit analysis will be undertaken to determine the impact of pharmaceutical care relative to total patient care costs. The main outcome results of the IMPROVE study are expected to be available in 1999. The IMPROVE project will be the first study of the impact of ambulatory care clinical pharmacists on patient outcomes.",
keywords = "Administration, Ambulatory care, Clinical pharmacists, Clinical pharmacy, Clinical studies, Costs, Department of Veterans Affairs, Economics, Errors, medication, Interventions Methodology, Outcomes, Patient care, Pharmaceutical care, Pharmaceutical services, Pharmacy, institutional, hospital, Prescriptions, Primary care, Toxicity",
author = "Carter, {Barry L.} and Malone, {Daniel C} and Valuck, {Robert J.} and Barnette, {Debra J.} and Sintek, {Charles D.} and Billups, {Sarah J.}",
year = "1998",
language = "English (US)",
volume = "55",
pages = "62--67",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "1",

}

TY - JOUR

T1 - The IMPROVE study

T2 - Background and study design

AU - Carter, Barry L.

AU - Malone, Daniel C

AU - Valuck, Robert J.

AU - Barnette, Debra J.

AU - Sintek, Charles D.

AU - Billups, Sarah J.

PY - 1998

Y1 - 1998

N2 - An ongoing study of the impact of ambulatory care clinical pharmacists on patient outcomes at selected Veterans Affairs medical centers (VAMCs) is described. The IMPROVE (Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers) study will examine the effects of referring patients at high risk for drug-related problems to a pharmacist-managed monitoring program. Nine study sites from diverse geographic locations and small and large urban areas have been selected. Investigators visited each site to evaluate the structure of care, observe pharmacist-patient interactions and assess the level and documentation of pharmacists activities. A coordinating center will collect and process patient-specific data from the study sites to identify high-risk patients. It is expected that 500 intervention patients and 500 control patients from the nine VAMCs will complete all portions of the study. Intervention patients will be scheduled for medication assessments by ambulatory care pharmacists and will be monitored by pharmacists for at least 12 months. The coordinating center will track refill histories for intervention patients. Investigators will assess the activities performed by ambulatory care pharmacists to determine predictors of successful patient outcomes. The two groups will be compared with respect to change from baseline in quality of life and satisfaction with health care providers. A cost-benefit analysis will be undertaken to determine the impact of pharmaceutical care relative to total patient care costs. The main outcome results of the IMPROVE study are expected to be available in 1999. The IMPROVE project will be the first study of the impact of ambulatory care clinical pharmacists on patient outcomes.

AB - An ongoing study of the impact of ambulatory care clinical pharmacists on patient outcomes at selected Veterans Affairs medical centers (VAMCs) is described. The IMPROVE (Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers) study will examine the effects of referring patients at high risk for drug-related problems to a pharmacist-managed monitoring program. Nine study sites from diverse geographic locations and small and large urban areas have been selected. Investigators visited each site to evaluate the structure of care, observe pharmacist-patient interactions and assess the level and documentation of pharmacists activities. A coordinating center will collect and process patient-specific data from the study sites to identify high-risk patients. It is expected that 500 intervention patients and 500 control patients from the nine VAMCs will complete all portions of the study. Intervention patients will be scheduled for medication assessments by ambulatory care pharmacists and will be monitored by pharmacists for at least 12 months. The coordinating center will track refill histories for intervention patients. Investigators will assess the activities performed by ambulatory care pharmacists to determine predictors of successful patient outcomes. The two groups will be compared with respect to change from baseline in quality of life and satisfaction with health care providers. A cost-benefit analysis will be undertaken to determine the impact of pharmaceutical care relative to total patient care costs. The main outcome results of the IMPROVE study are expected to be available in 1999. The IMPROVE project will be the first study of the impact of ambulatory care clinical pharmacists on patient outcomes.

KW - Administration

KW - Ambulatory care

KW - Clinical pharmacists

KW - Clinical pharmacy

KW - Clinical studies

KW - Costs

KW - Department of Veterans Affairs

KW - Economics

KW - Errors, medication

KW - Interventions Methodology

KW - Outcomes

KW - Patient care

KW - Pharmaceutical care

KW - Pharmaceutical services

KW - Pharmacy, institutional, hospital

KW - Prescriptions

KW - Primary care

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=0031984110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031984110&partnerID=8YFLogxK

M3 - Article

VL - 55

SP - 62

EP - 67

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 1

ER -